LONGITUDINAL CHANGES IN MULTIPLE BIOMARKERS ARE ASSOCIATED WITH CARDIOTOXICITY IN BREAST CANCER PATIENTS TREATED WITH DOXORUBICIN, TAXANES AND TRASTUZUMAB

被引：0
|
作者：
Hahn, Virginia Shalkey
Putt, Mary
Sawaya, Heloisa
Januzzi, James
Sebag, Igal A.
Plana, Juan
Picard, Michael
Gerszten, Robed
Halpern, Elkan
Kuter, Irene
Martin, Randolph
Carver, Joseph
Scherrer-Crosbie, Marielle
Ky, Bonnie
机构：
[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)61001-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1217-224
引用
收藏
页码：A1001 / A1001
页数：1
相关论文
共 50 条
  • [41] Evaluation of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Treated With Radiation Therapy and Trastuzumab
    Bachir, B.
    Anouti, S.
    Jaoude, J. Abi
    Kayali, M.
    Tfayli, A.
    De Azambuja, E.
    Poortmans, P.
    Zeidan, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S7 - S7
  • [42] Evaluation of Cardiotoxicity in HER-2-Positive Breast Cancer Patients Treated With Radiation Therapy and Trastuzumab
    Bachir, Bachir
    Anouti, Sirine
    Jaoude, Joseph Abi
    Kayali, Majd
    Tfayli, Arafat
    de Azambuja, Evandro
    Poortmans, Philip
    Zeidan, Youssef H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (01): : 135 - 142
  • [43] Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients
    Nyangwara, Vincent Aketch
    Mazhindu, Tinashe
    Chikwambi, Zedias
    Masimirembwa, Collen
    Campbell, Thomas B.
    Borok, Margaret
    Ndlovu, Ntokozo
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (08) : 1782 - 1789
  • [44] Cardiotoxicity Associated with Trastuzumab in Breast Cancer Patients: Definition of Cancer Therapeutics-Related Cardiac Dysfunction (CTRCD)
    Shioyama, Wataru
    Mukai, Mikio
    Oka, Toru
    Tone, Eirou
    Awata, Nobuhisa
    Hori, Masatsugu
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (10) : S194 - S194
  • [45] Detection of Subclinical Trastuzumab-Induced Cardiotoxicity in Patients with Breast Cancer
    Higuchi dos Santos, Marilia Harumi
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2013, 101 (01) : 2 - 3
  • [46] Risks of trastuzumab-related cardiotoxicity in breast cancer patients in Taiwan
    Chang, W. T. C.
    Chen, P. W. C.
    Lin, H. W. L.
    Lin, H. S. L.
    Li, Y. H. L.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2835 - 2835
  • [47] Risks of trastuzumab-related cardiotoxicity in breast cancer patients in Taiwan
    Chang, Wei-Ting
    Chen, Po-Wei
    Lin, Hui-Wen
    Lin, Sheng-Hsiang
    Li, Yi-Heng
    ESC HEART FAILURE, 2021, 8 (06): : 5149 - 5158
  • [48] Does Trastuzumab Cause Cardiotoxicity in the Treatment of Patients with Breast Cancer? Reply
    Tan, Timothy C.
    Scherrer-Crosbie, Marielle
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2015, 28 (09) : 1129 - 1130
  • [49] Risks of trastuzumab-related cardiotoxicity in breast cancer patients in Taiwan
    Chang, Wei-Ting
    Chen, Po-Wei
    Lin, Hui-Wen
    Lin, Sheng-Hsiang
    Li, Yi-Heng
    ESC HEART FAILURE, 2022, 8 (06): : 5149 - 5158
  • [50] Cardiotoxicity Risks of Adjuvant Trastuzumab in Asian Breast Cancer Patients.
    Shih, V.
    Chan, A.
    Sim, M. H.
    Teo, C.
    Chen, W.
    Wong, Z. W.
    CANCER RESEARCH, 2011, 71
12345